However, for reasons of technical feasibility, mimicking circadian PTH secretion failed and hyperphosphatemia was observed during the continuous pump administration, as opposed to the bi-daily sub-cutaneous administration. The gene discussed is PTH; the disease is hyperphosphatemia.